1
Variant Market Research
Global Biosimilars Market is estimated to reach $46.0 Billion by 2025, Says Variant Market Research
Bhavana Patel SEO Analyst help@variantmarketresearch.com
help@variantmarketresearch.com | sales@variantmarketresearch.com
2
Variant Market Research
Global Biosimilars Market is estimated to reach $46.0 Billion by 2025; growing at a CAGR of 33% from 2017 to 2025. Biosimilars are the biotechnological product that is proved to be comparable to an already approved reference product in quality, non�clinical and clinical evaluation. The generic equivalents of biologics are meant as a ‘biosimilars’. A biosimilar is a highly similar, comparable version of an approved biologic medicine, which undergo through clinical trials to demonstrate that it works just as the approved biologic medicine. It is used to treat a wide range of conditions including cancer and autoimmune diseases. Regulatory guidelines for biosimilar development and approval are rigorous and undergoing constant refinement. Biosimilars offer good alternate treatment options in patients who cannot be treated with synthetic DMARDs (Disease-modifying antirheumatic drugs). Click
Here
to
Request
a
Free
Sample
of
This
Report
@
https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biosimilarsmarket/sample-request
Increasing incidence of chronic diseases such as arthritis, asthma, cancer, COPD, diabetes and some viral diseases are the primary driver fueling the growth of the market. Additionally, rising demand for biosimilar medicines owing to their cost-effectiveness have also stimulated the market growth. However, complexity in manufacturing is the restraint of the market. Moreover, growth opportunities in emerging markets are expected to equally influence the overall growth of market during the forecast period.
help@variantmarketresearch.com | sales@variantmarketresearch.com
3
Variant Market Research
Product, manufacturing type, disease and geography are the segment of biosimilars market. The product segment is categorized into recombinant non-glycosylated proteins (insulin, interferon, recombinant human growth hormone, and granulocyte colony-stimulating factor), recombinant glycosylated proteins (erythropoietin, follitropin, and monoclonal antibodies), and recombinant peptides (glucagon, and calcitonin). In-house manufacturing and contract manufacturing are the bifurcations of manufacturing type. Furthermore, oncology, chronic diseases, growth hormone deficiency, blood disorders, infectious diseases, autoimmune diseases, and other diseases are segregated under disease segment. Get
Full
Access
to
This
Report
@
https://www.variantmarketresearch.com/report-
categories/pharmaceuticals/biosimilars-market
On the basis of geography, global biosimilars market is segmented into North America, Europe, AsiaPacific and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexico whereas Europe consists of UK, Germany, France, Italy and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea and Rest of Asia-Pacific while RoW is bifurcated into South America, Middle East, and Africa.
help@variantmarketresearch.com | sales@variantmarketresearch.com
4
Variant Market Research
Major companies operating in the global market include Celltrion Inc., Biocon, Hospira Inc., Merck KGaA, Biogen, Genentech, Inc., LG Life Sciences, Novartis AG, Synthon, and Teva Pharmaceutical Industries Ltd., among others. The key takeaways from the report •
The report will provide detailed analysis of Global Biosimilars Market with respect to major segments such as product, manufacturing type, disease and geography
•
The report will include the qualitative and quantitative analysis with market estimation over 2016 – 2025 and compound annual growth rate (CAGR) between 2017 and 2025
•
Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
•
An exhaustive regional analysis of Global Biosimilars Market has been included in the report
•
Profile of the key players in the Global Biosimilars Market will be provided, which include key financials, product & services, new developments and business strategies
Scope of the Global Biosimilars Market Product Segments •
Recombinant Non-Glycosylated Proteins o
Insulin
o
Interferon
o
Recombinant Human Growth Hormone
help@variantmarketresearch.com | sales@variantmarketresearch.com
5
Variant Market Research
o •
•
Granulocyte Colony-Stimulating Factor
Recombinant Glycosylated Proteins o
Erythropoietin
o
Follitropin
o
Monoclonal Antibodies
Recombinant Peptides o
Glucagon
o
Calcitonin
Manufacturing Type Segments •
In-House Manufacturing
•
Contract Manufacturing
Disease Segments •
Oncology
•
Chronic Diseases
•
Growth Hormone Deficiency
•
Blood Disorders
•
Infectious Diseases
•
Autoimmune Diseases
•
Other Diseases
Geographical Segments •
•
•
North America o
U.S.
o
Canada
o
Mexico
Europe o
UK
o
Germany
o
France
o
Italy
o
Rest of Europe
Asia-Pacific help@variantmarketresearch.com | sales@variantmarketresearch.com
6
Variant Market Research
•
o
India
o
China
o
Japan
o
South Korea
o
Rest of Asia-Pacific
RoW o
South America
o
Middle East
o
Africa
Table of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research
help@variantmarketresearch.com | sales@variantmarketresearch.com
7
Variant Market Research
1.3.3 In-house Data Modeling Chapter 2 Executive Summary 2.1 Global Biosimilars Market Year-on-Year Growth, 2017 – 2025 (%) Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Market Dynamics 3.3.1 Drivers 3.3.1.1 Impact Analysis 3.3.2 Restraints 3.3.2.1 Impact Analysis 3.3.3 Opportunities ...... Chapter 8 Company Profiles 8.1 Celltrion Inc. 8.2 Biocon 8.3 Merck KGaA 8.4 BIOGEN 8.5 Genentech, Inc. 8.6 LG LIFE SCIENCES help@variantmarketresearch.com | sales@variantmarketresearch.com
8
Variant Market Research
8.7 Novartis AG 8.8 Synthon 8.9 Teva Pharmaceutical Industries Ltd. 8.10 Hospira Inc. About Variant Market Research Variant Market Research offers syndicated and customized reports to fulfil clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise is data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024. For further information, visit https://www.variantmarketresearch.com You can connect with us on LinkedIn here @ https://www.linkedin.com/company/variant-marketresearch Contact Us: John Dave, Head - Sales Variant Market Research 649 Mission St, 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: john.dave@variantmarketresearch.com Email: help@variantmarketresearch.com help@variantmarketresearch.com | sales@variantmarketresearch.com